Prof Stricker and A/Prof Emmett have recently published a study comparing PSMA PET/CT scan to the more established Choline PET-CT scan. It confirmed that PSMA PET/CT scaning is much more accurate.
Prof Stricker is now conducting trials looking at patients with high-risk cancers using this new PET scanning to allow more appropriate therapy, particularly in high-volume, intermediate-risk cancers and high-risk prostate cancer.
A trial looking at the accuracy of the scan is also going to be combined with a new ultra-sensitive form of MRI (Combidex MRI).